PHARMARON (03759): Professor Zeng Jinfeng Appointed as Independent Non-Executive Director
Stock News
Yesterday
PHARMARON (03759) announced that Professor Zeng Jinfeng has been appointed as an independent non-executive director of the third board of directors, effective from December 18, 2025, following the formal approval of the relevant resolution at the extraordinary general meeting. Additionally, Mr. Zeng Kunhong has stepped down from his roles as independent non-executive director, member of the board's audit committee, compensation and evaluation committee, and nomination committee, effective concurrently with Professor Zeng Jinfeng's appointment on December 18, 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.